Literature DB >> 23567083

Reversion of hepatic stellate cell to a quiescent phenotype: From myth to reality?

Ariane Mallat1, Sophie Lotersztajn.   

Abstract

Keywords:  Fibrosis; Hepatic stellate cells; Reversion

Mesh：

Substances：

Year:  2013        PMID： 23567083     DOI： 10.1016/j.jhep.2013.03.031

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

Review 1.  Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.

Authors:  Chong-Yang Zhang; Wei-Gang Yuan; Pei He; Jia-Hui Lei; Chun-Xu Wang
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

Review 2.  Reversal of liver cirrhosis: current evidence and expectations.

Authors:  Young Kul Jung; Hyung Joon Yim
Journal:  Korean J Intern Med       Date:  2017-02-08       Impact factor: 2.884

3.  Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis.

Authors:  Yitong Zhang; Jing Liu; Yanyun Ma; Jingjie Wang; Jie Zhu; Jie Liu; Jun Zhang
Journal:  Mol Med Rep       Date:  2018-11-09       Impact factor: 2.952

4.  Astragaloside IV regulates NF-κB-mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF-BB-induced activation.

Authors:  Zhiwei Chen; Ling Yao; Yuanyuan Liu; Zheng Pan; Shuang Peng; Guoguo Wan; Junxiong Cheng; Jianwei Wang; Wenfu Cao
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447

5.  Cellular and molecular effects of Baccharis dracunculifolia D.C. and Plectranthus barbatus Andrews medicinal plant extracts on retinoid metabolism in the human hepatic stellate cell LX-2.

Authors:  Caio Mateus da Silva; Flávio Henrique Caetano; Franco Dani Campos Pereira; Maria Aparecida Marin Morales; Kumiko Koibuchi Sakane; Karen C M Moraes
Journal:  BMC Complement Altern Med       Date:  2019-08-22       Impact factor: 3.659

Review 6.  Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.

Authors:  Zuzanna Sas; Ewa Cendrowicz; Isabel Weinhäuser; Tomasz P Rygiel
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

7.  The role of mouse strain differences in the susceptibility to fibrosis: a systematic review.

Authors:  Louise Walkin; Sarah E Herrick; Angela Summers; Paul E Brenchley; Catherine M Hoff; Ron Korstanje; Peter J Margetts
Journal:  Fibrogenesis Tissue Repair       Date:  2013-09-25

8.  Progressive Fibrosis Is Driven by Genetic Predisposition, Allo-immunity, and Inflammation in Pediatric Liver Transplant Recipients.

Authors:  S Varma; J Ambroise; M Komuta; D Latinne; P Baldin; R Reding; F Smets; X Stephenne; E M Sokal
Journal:  EBioMedicine       Date:  2016-06-01       Impact factor: 8.143
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.